Tag: market
Akebia crashes on vadadustat flop in larger anemia indication. Will AZ,...
What was previously expected to be a three-way battle in the novel HIF-PHI renal anemia drug class now has one man down. Akebia Therapeutics has...
Bristol Myers Squibb’s Zeposia launches into crowded MS market
When Bristol Myers Squibb nabbed Celgene's long-sought FDA nod for multiple sclerosis drug Zeposia, the COVID-19 pandemic was in full swing—not the ideal time...
With nod in older adults, Merck drives HPV shot Gardasil 9...
With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients....
Roche’s fast-moving Hemlibra breaks into wider hemophilia market with blockbuster approval
Roche’s Hemlibra officially has the hemophilia indication it’s been waiting for—and that its competitors have been dreading.
On Thursday, the FDA approved the drug to...
